top of page
INfluenza Vaccine to Effectively Stop cardioThoracic Events and Decompensated heart failure Trial
The INVESTED Trial is designed to determine which of two formulations of influenza vaccine, the standard dose or an investigational higher dose, is more effective in reducing deaths and heart- or lung-related admissions to the hospital.
1/31/19 INVESTED 2018-19 enrollment season ended with a total of 5386 participants enrolled!
9/24/18 First new participant enrolled for the 2018-19 season!
5/22/18 INVESTED Trial Design Paper published in American Heart Journal
bottom of page